BENZALKONIUM CHLORIDE 0.13% and DRUG INEFFECTIVE

Overview

DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE 0.13%, manufactured by Meijer, Inc.. There are 124 FDA adverse event reports linking BENZALKONIUM CHLORIDE 0.13% to DRUG INEFFECTIVE. This represents approximately 3.7% of all 3,369 adverse event reports for this drug.

Patients taking BENZALKONIUM CHLORIDE 0.13% who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE124 of 3,369 reports

DRUG INEFFECTIVE is moderately reported among BENZALKONIUM CHLORIDE 0.13% users, representing a notable but not dominant share of adverse events.

Other Side Effects of BENZALKONIUM CHLORIDE 0.13%

In addition to drug ineffective, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE 0.13%:

DRUG HYPERSENSITIVITY — 116 reports
CONDITION AGGRAVATED — 112 reports
ARTHRALGIA — 110 reports
THERAPY NON RESPONDER — 110 reports
MUSCULOSKELETAL STIFFNESS — 108 reports
PAIN IN EXTREMITY — 108 reports
INFECTION — 107 reports
HEPATOTOXICITY — 105 reports
JOINT SWELLING — 105 reports
MUSCULOSKELETAL PAIN — 105 reports

Other Drugs Associated with DRUG INEFFECTIVE

The following drugs have also been linked to drug ineffective in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABEMACICLIB ABIRATERONE ACETATE ACETAMINOPHEN ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE

Does BENZALKONIUM CHLORIDE 0.13% cause DRUG INEFFECTIVE?

DRUG INEFFECTIVE has been reported as an adverse event in 124 FDA reports for BENZALKONIUM CHLORIDE 0.13%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE with BENZALKONIUM CHLORIDE 0.13%?

DRUG INEFFECTIVE accounts for approximately 3.7% of all adverse event reports for BENZALKONIUM CHLORIDE 0.13%, making it one of the most commonly reported side effect.

What should I do if I experience DRUG INEFFECTIVE while taking BENZALKONIUM CHLORIDE 0.13%?

If you experience drug ineffective while taking BENZALKONIUM CHLORIDE 0.13%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.